Neuroprotective Effect of siRNA Entrapped in Hyaluronic Acid-Coated Lipoplexes by Intravitreal Administration
Authors:
- Marcela Coelho Silva RibeiroMRMarcela Coelho Silva Ribeiro
- Marcelo Coutinho de MirandaMMMarcelo Coutinho de Miranda
- Pricila da Silva CunhaPCPricila da Silva Cunha
- Gracielle Ferreira AndradeGAGracielle Ferreira Andrade
- Gustavo de Oliveira FulgêncioGFGustavo de Oliveira Fulgêncio
- Dawidson Assis GomesDGDawidson Assis Gomes
- Sílvia Ligorio FialhoSFSílvia Ligorio Fialho
- Frederico PittellaFPFrederico Pittella
- Christine CharrueauCCChristine Charrueau
- Virginie EscriouVEVirginie Escriou
- Armando Silva-CunhaASArmando Silva-Cunha
Open Access
- 8 June 2021
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 13 (6) , 845
Abstract
Since the possibility of silencing specific genes linked to retinal degeneration has become a reality with the use of small interfering RNAs (siRNAs), this technology has been widely studied to promote the treatment of several ocular diseases. Despite recent advances, the clinical success of gene silencing in the retina is significantly reduced by inherent anatomical and physiological ocular barriers, and new strategies are required to achieve intraocular therapeutic effectiveness. In this study, we developed lipoplexes, prepared with sodium alginate as an adjuvant and strategically coated with hyaluronic acid (HA-LIP), and investigated the potential neuroprotective effect of these systems in a retinal light damage model. Successful functionalization of the lipoplexes with hyaluronic acid was indicated in the dynamic light scattering and transmission electron microscopy results. Moreover, these HA-LIP nanoparticles were able to protect and deliver siRNA molecules targeting caspase-3 into the retina. After retinal degeneration induced by high light exposure, in vitro and in vivo quantitative reverse transcription-PCR (RT-qPCR) assays demonstrated significant inhibition of caspase-3 expression by HA-LIP. Furthermore, these systems were shown to be safe, as no evidence of retinal toxicity was observed by electroretinography, clinical evaluation or histology.Keywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (150010/2018-4)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2014/50928-2)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (23038.000776/2017O54)
- CAPES / COFECUB (860/15)
This publication has 47 references indexed in Scilit:
- Strategies for ocular siRNA delivery: Potential and limitations of non-viral nanocarriersJournal of Biological Engineering, 2012
- Hyaluronic acid-bearing lipoplexes: Physico-chemical characterization and in vitro targeting of the CD44 receptorJournal of Controlled Release, 2012
- Liposomes for intravitreal drug delivery: A state of the artJournal of Controlled Release, 2012
- Ocular neuroprotection by siRNA targeting caspase-2Cell Death & Disease, 2011
- Retinal light damage: Mechanisms and protectionProgress in Retinal and Eye Research, 2010
- Efficient Cellular Labeling by CD44 Receptor‐Mediated Uptake of Cationic Liposomes Functionalized with Hyaluronic Acid and Loaded with MRI Contrast AgentsChemMedChem, 2008
- Downregulation of Endotoxin-Induced Uveitis by Intravitreal Injection of Vasoactive Intestinal Peptide Encapsulated in LiposomesInvestigative Ophthalmology & Visual Science, 2007
- Caspase-Dependent Apoptosis in Light-Induced Retinal DegenerationInvestigative Ophthalmology & Visual Science, 2007
- Non-viral ocular gene therapy: Potential ocular therapeutic avenuesAdvanced Drug Delivery Reviews, 2006
- Relative expression software tool (REST(C)) for group-wise comparison and statistical analysis of relative expression results in real-time PCRNucleic Acids Research, 2002